Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone versus betamethasone for lateral epicondylitis
IRCT20190610043858N1Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jul 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of methylprednisolone and betamethasone in Lateral Epicondylitis (LET) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Visual Analog Scale, Quick Disabilities of the Arm, Shoulder and Hand and 1 more. Started Jul 2025; status: completed.
02
Drugs
methylprednisolonebetamethasone
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on IRCT20190610043858N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190610043858N1.